期刊
JOURNAL OF IMMUNOLOGY
卷 178, 期 9, 页码 5473-5479出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.178.9.5473
关键词
-
类别
资金
- NIAMS NIH HHS [K08 AR 49444-02] Funding Source: Medline
- NIA NIH HHS [P30 AG 21342] Funding Source: Medline
IL-7 is critical for the development and survival of T cells. Recently, we found two subsets of human CD8(+) T cells expressing IL-7R alpha(high) and IL-7R alpha(low) with different cell survival responses to IL-7. Although these CD8(+) T cell subsets have differential IL-7R alpha gene expression, the mechanism for this is unknown. DNA methylation is an important gene regulatory mechanism and is associated with the inactivation of gene expression. Thus, we investigated a role for DNA methylation in differentially regulating IL-7R alpha gene expression in human CD8(+) T cells and Jurkat T cells. IL-7R alpha(high)CD8+ T cells had decreased methylation in the IL-7R alpha gene promoter compared with IL-7R alpha(low)CD8(+) T cells and Jurkat T cells with low levels of IL-7R alpha. Treating Jurkat T cells with 5-aza-2'-deoxycytidine, which reduced DNA methylation, increased IL-7R alpha expression. Plus, the unmethylated IL-7R alpha gene promoter construct had higher levels of promoter activity than the methylated one as measured by a luciferase reporter assay. These findings suggest that DNA methylation is involved in regulating IL-7R alpha expression in T cells via affecting IL-7R alpha gene promoter activity, and that the methylation of this gene promoter could be a potential target for modifying IL-7-mediated T cell development and survival.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据